QT Dispersion after Thrombolytic Therapy

Area of Science:

• Cardiology
• Electrophysiology
• Acute Myocardial Infarction Research

Background:

• QT dispersion (QTd) quantifies ventricular repolarization inhomogeneity using 12-lead ECG.
• QTd is a valuable predictor of arrhythmia risk in Acute Myocardial Infarction (AMI) patients.
• Assessing QTd changes after thrombolytic therapy is crucial for understanding post-MI cardiac risk.

Purpose of the Study:

• To evaluate the impact of thrombolytic therapy on QT dispersion (QTd).
• To determine if thrombolytic therapy affects arrhythmia risk by monitoring QTd.
• To analyze QTd changes at specific time points: before, 1 hour, and 4 days post-therapy.

Main Methods:

• Patients with ST-Elevated Myocardial Infarction (STEMI) receiving streptokinase were enrolled.
• Standard 12-lead ECGs were analyzed for QT and QTd measurements before, 1 hour, and 4 days after thrombolysis.
• One-way ANOVA was used for statistical comparison of QTd values, with P ≤ 0.05 considered significant.

Main Results:

• No significant differences in QT dispersion were found among the three measurement points in the overall patient cohort (P > 0.05).
• A statistically significant difference in QT dispersion was observed in patients with inferior AMI (P = 0.031).
• The study included 160 patients undergoing thrombolytic therapy.

Conclusions:

• Thrombolytic therapy, including streptokinase, does not significantly affect overall QT dispersion.
• The findings suggest that thrombolytic therapy does not elevate the risk of cardiac arrhythmias.
• Further investigation into specific AMI locations, like inferior AMI, may be warranted regarding QT dispersion dynamics.